This inventor holds 1 USPTO granted patent. Top assignee: Purdue Research Foundation. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: NaMi McCarty: Innovator in Monoclonal Antibody Research
Introduction
NaMi McCarty is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work focuses on the diagnosis of neoplastic tissues, which is crucial for cancer detection and treatment.
Latest Patents
NaMi McCarty holds a patent for "Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase." This patent describes compositions and methods for diagnosing neoplastic tissue. The monoclonal antibodies developed by McCarty specifically recognize the tumor cell-specific NADH:protein thiol reductase. Additionally, the patent includes hybridoma cell lines that produce these antibodies, along with diagnostic and immunohistological assays for identifying neoplastic cells.
Career Highlights
McCarty is associated with the Purdue Research Foundation, where he continues to advance his research in monoclonal antibodies. His innovative work has the potential to improve cancer diagnostics and treatment options significantly.
Collaborations
NaMi McCarty has collaborated with notable colleagues, including D James Morré and Dorothy M Morré. Their combined expertise enhances the research efforts in the field of neoplastic tissue diagnosis.
Conclusion
NaMi McCarty's contributions to monoclonal antibody research represent a significant advancement in cancer diagnostics. His innovative approaches and collaborations continue to pave the way for improved medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile